← Browse by Condition
Medical Condition

pregnancy complications

Total Trials
14
Recruiting Now
14
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for pregnancy complications sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — pregnancy complications Clinical Trials

How many clinical trials are currently recruiting for pregnancy complications?
ClinicalMetric currently tracks 14 actively recruiting clinical trials for pregnancy complications, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pregnancy complications?
pregnancy complications research spans Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pregnancy complications clinical trial?
Eligibility criteria for pregnancy complications trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
2
Top Sponsors
IRCCS San Raffaele 2 trials
McMaster University 1 trial
University of Tennessee Graduate School of Medicine 1 trial
Ain Shams University 1 trial
Chiesi Farmaceutici S.p.A. 1 trial

Recruiting Clinical Trials

NCT05114096 Phase 4
Recruiting
Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)
Enrollment
3,254 pts
Location
Canada
Sponsor
McMaster University
View Trial →
NCT05786235
Recruiting
Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome
Enrollment
60 pts
Location
Italy
Sponsor
IRCCS San Raffaele
View Trial →
NCT07565727
Recruiting
Cardiometabolic Disease and Substrate Metabolism
Enrollment
50 pts
Location
United States
Sponsor
University of Tennessee Gradua...
View Trial →
NCT05807256
Recruiting
Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
Enrollment
500 pts
Location
Italy
Sponsor
IRCCS San Raffaele
View Trial →
NCT06728722
Recruiting
Ultrasound Detection of Body Composition in Critical Care
Enrollment
121 pts
Location
Egypt
Sponsor
Ain Shams University
View Trial →
NCT06941025
Recruiting
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
Enrollment
10 pts
Location
United States, Germa...
Sponsor
Chiesi Farmaceutici S.p.A.
View Trial →
NCT05234125
Recruiting
Better Lifestyle Counseling for African American Women During Pregnancy
Enrollment
150 pts
Location
United States
Sponsor
University of Illinois Chicago
View Trial →
NCT07009704
Recruiting
Glucose Empowerment Through Monitoring and Social Support in Pregnancy
Enrollment
70 pts
Location
United States
Sponsor
Tufts Medical Center
View Trial →
NCT06542718
Recruiting
Studying Phenotypes of Gestational Diabetes Mellitus in an Asian Pregnant Cohort
Enrollment
800 pts
Location
Singapore
Sponsor
National University Health Sys...
View Trial →
NCT06861309
Recruiting
Placental Imaging Techniques
Enrollment
60 pts
Location
United States
Sponsor
Carilion Clinic
View Trial →
NCT05753124
Recruiting
Effect of Obesity, Diabetes and Bariatric Surgery on Pregnancy Outcomes
Enrollment
700 pts
Location
United Kingdom
Sponsor
Chelsea and Westminster NHS Fo...
View Trial →
NCT05503849
Recruiting
Born In Guangzhou Intervention Study
Enrollment
1,160 pts
Location
China
Sponsor
Guangzhou Women and Children's...
View Trial →
NCT06281665 Phase 4
Recruiting
Treatment With Aspirin After Preeclampsia: TAP Trial
Enrollment
60 pts
Location
United States
Sponsor
Malamo Countouris
View Trial →
NCT06449430
Recruiting
Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic Version
Enrollment
270 pts
Location
Spain
Sponsor
Fundacion para la Formacion e ...
View Trial →

Related Conditions

preeclampsia (3) gestational diabetes (3) pregnancy (3) pregnancy related (3) immunologic disease (2) pregnancy high risk (2) rheumatic diseases (2) pregnancy outcomes (2) preterm birth (1) premature birth (1) complication of prematurity (1) obstetric labor premature (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology